Multiple endocrine neoplasia type 2 other imaging findings: Difference between revisions
(Created page with "__NOTOC__ {{Multiple endocrine neoplasia type 2}} {{CMG}}; {{AE}} {{Ammu}} ==Overview== ==Other Imaging Studies== * [18F]-fluorodopamine ([18F]DA) PET is the best imaging m...") |
No edit summary |
||
Line 6: | Line 6: | ||
==Other Imaging Studies== | ==Other Imaging Studies== | ||
* [18F]-fluorodopamine ([18F]DA) PET is the best imaging modality for pheochromocytoma | * [18F]-fluorodopamine ([18F]DA) PET is the best imaging modality for pheochromocytoma | ||
* MIBG (123I- or 131I- metaiodobenzylguanidine) scintigraphy is another imaging modality for pheochromocytoma | |||
* MIBG (123I- or 131I- metaiodobenzylguanidine) scintigraphy is another imaging modality for pheochromocytoma. | * 99mTc-sestamibi scintigraphy is a good imaging modality for hyperparathyroidism. |
Revision as of 19:52, 21 September 2015
Multiple endocrine neoplasia type 2 Microchapters |
Differentiating Multiple endocrine neoplasia type 2 from other Diseases |
---|
Diagnosis |
Treatment |
Multiple endocrine neoplasia type 2 other imaging findings On the Web |
American Roentgen Ray Society Images of Multiple endocrine neoplasia type 2 other imaging findings |
FDA on Multiple endocrine neoplasia type 2 other imaging findings |
CDC on Multiple endocrine neoplasia type 2 other imaging findings |
Multiple endocrine neoplasia type 2 other imaging findings in the news |
Blogs on Multiple endocrine neoplasia type 2 other imaging findings |
Directions to Hospitals Treating Multiple endocrine neoplasia type 2 |
Risk calculators and risk factors for Multiple endocrine neoplasia type 2 other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Other Imaging Studies
- [18F]-fluorodopamine ([18F]DA) PET is the best imaging modality for pheochromocytoma
- MIBG (123I- or 131I- metaiodobenzylguanidine) scintigraphy is another imaging modality for pheochromocytoma
- 99mTc-sestamibi scintigraphy is a good imaging modality for hyperparathyroidism.